Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fast Titration of Quetiapine in Schizophrenia
NCT00304473Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in schizophrenia, sponsored by AstraZeneca. Started Aug 2004; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00304473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304473.